Compare DigiByte (DGB) vs Mira (MIRA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigiByte vs Mira — how do they compare? DigiByte trades at Rp72.5 (market cap Rp1,34T, Rp41,84M 24h volume), while Mira trades at Rp700.16 (market cap Rp226,43M, Rp101,47M 24h volume). The key difference: DigiByte is far larger — about 5917.9× Mira's market cap, and DigiByte's circulating supply is 18,4B / 21B DGB (88%) versus 321,5M / 1B MIRA (33%) for Mira. Which is the better fit depends on your goals — on Pluang, investors hold DigiByte for 22 Days and Mira for 22 Days on average.
| DGB | MIRA | |
|---|---|---|
Market Cap | Rp1,34T | Rp226,43M |
Volume (24h) | Rp41,84M | Rp101,47M |
Circulating Supply | 18,4B / 21B DGB (88%) | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 22 Days | 22 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigiByte is trading at Rp73.499 with a market cap of Rp1.35T, showing bullish technical signals with strong moving average support and key indicators favoring buying activity. The asset maintains 88% circulation rate with support levels at Rp69-72 and resistance at Rp75-78. Recent technical momentum suggests upward potential despite neutral RSI readings.
Overall outlook remains positive with strong technical momentum, though investors should monitor resistance levels and cryptocurrency market volatility. Key opportunities include potential breakout above resistance, while risks involve typical crypto volatility and regulatory uncertainties affecting the broader digital asset space.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About DigiByte
DigiByte (DGB) is an open-source blockchain and asset creation platform. Its development started in October 2013, and its genesis block was mined in January 2014 as a fork of Bitcoin (BTC).
Read more on DGB →About Mira
Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →
